Vitrolife
16
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.8%
3 terminated/withdrawn out of 16 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
44%
4 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
eValuating iDA Selection Ability. The VISA Study.
Role: lead
Comparing KIDScore™ D5 and iDAScore®. The KiDA Study
Role: lead
G-IVF and Sperm Parameters
Role: lead
Evaluating Piezo-ICSI. - The EPI Study.
Role: lead
Experience of Pain During Oocyte Retrieval- a Comparison Between Two Aspiration Needles
Role: lead
Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse Imaging
Role: lead
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
Role: collaborator
Adding Antioxidants Into Human Sequential Culture Media System
Role: lead
KIDScore D3 Clinical Study
Role: lead
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Role: collaborator
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Role: collaborator
Comparisons of Human Embryonic Development Using Single Medium With and Without the Addition of Antioxidants
Role: collaborator
Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media
Role: collaborator
Performance Study of New Media for Vitrification of Human Oocytes
Role: lead
Vitrification and Slow Freezing for Cryopreservation of Blastocyst
Role: collaborator
Comparison of Single vs Group Embryo Culture in Micro-well Group Culture Dish
Role: collaborator
All 16 trials loaded